Contribution of the P2Y12 receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia.
BACKGROUND
In hypercholesterolemia, platelets demonstrate increased reactivity and promote the development of cardiovascular disease.


OBJECTIVE
This study was carried out to investigate the contribution of the ADP receptor P2Y12-mediated pathway to platelet hyperreactivity due to hypercholesterolemia.


METHODS
Low-density lipoprotein receptor-deficient mice and C57Bl/6 wild-type mice were fed on normal chow and high-fat (Western or Paigen) diets for 8 weeks to generate differently elevated cholesterol levels. P2Y12 receptor-induced functional responses via G(i) signaling were studied ex vivo when washed murine platelets were activated by 2MeSADP and PAR4 agonist AYPGKF in the presence and absence of indomethacin. Platelet aggregation and secretion, α(IIb)β(3) receptor activation and the phosphorylation of extracellular signal-regulated protein kinase (ERK) and Akt were analyzed.


RESULTS
Plasma cholesterol levels ranged from 69 ± 10 to 1011 ± 185 mg dL(-1) depending on diet in mice with different genotypes. Agonist-dependent aggregation, dense and α-granule secretion and JON/A binding were gradually and significantly (P < 0.05) augmented at low agonist concentration in correlation with the increasing plasma cholesterol levels, even if elevated thromboxane generation was blocked. These functional responses were induced via increased levels of G(i) -mediated ERK and Akt phosphorylation in hypercholesterolemic mice vs. normocholesterolemic animals. In addition, blocking of the P2Y12 receptor by AR-C69931MX (Cangrelor) resulted in strongly reduced platelet aggregation in mice with elevated cholesterol levels compared with normocholesterolemic controls.


CONCLUSIONS
These data revealed that the P2Y12 receptor pathway was substantially involved in platelet hyperreactivity associated with mild and severe hypercholesterolemia.
Department of Physiology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
B
B
Nagy
J
J
Jin
B
B
Ashby
M P
MP
Reilly
S P
SP
Kunapuli
D000818:Animals; D001792:Blood Platelets / Q000473:pathology*; D004591:Electrophoresis, Polyacrylamide Gel; D005434:Flow Cytometry; D006937:Hypercholesterolemia / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D058925:Receptors, Purinergic P2Y12 / Q000502:physiology*
D058925:Receptors, Purinergic P2Y12; D051057:Proto-Oncogene Proteins c-akt
Circulation. 2001 Nov 6;104(19):2331-7
11696474
Thromb Haemost. 2009 Jan;101(1):157-64
19132203
Microvasc Res. 2009 May;77(3):364-9
19323972
N Engl J Med. 1974 Feb 21;290(8):434-8
4359434
Biochim Biophys Acta. 2010 Mar;1798(3):389-400
19962956
J Thromb Haemost. 2006 Mar;4(3):638-47
16460446
Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):1013-8
8696940
Clin Chem Lab Med. 2004 May;42(5):475-86
15202782
Semin Thromb Hemost. 1993;19(2):115-21
8356456
Circulation. 1998 Mar 17;97(10):953-7
9529262
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):11069-74
16835302
J Biol Chem. 2004 Feb 6;279(6):4186-95
14623889
Br J Clin Pharmacol. 1997 Jul;44(1):77-83
9241100
Can J Physiol Pharmacol. 2008 Apr;86(4):153-9
18418423
Thromb Res. 2009 Jul;124(3):318-22
19012950
Atherosclerosis. 1985 Oct;57(1):65-73
3841001
J Clin Invest. 2004 Feb;113(3):340-5
14755328
Int J Biochem Cell Biol. 2008;40(11):2374-8
18468940
J Exp Med. 2002 Oct 7;196(7):887-96
12370251
Circ Res. 2008 Jun 20;102(12):1512-9
18497330
Biochim Biophys Acta. 1995 Mar 2;1255(1):87-97
7893743
Biochem J. 2007 Jun 1;404(2):299-308
17298299
Blood. 2002 Jan 1;99(1):193-8
11756171
Circulation. 2002 Sep 3;106(10):1282-7
12208806
Circulation. 1995 Dec 1;92(11):3172-7
7586300
Eur J Clin Invest. 2002 Dec;32(12):901-8
12534449
JAMA. 1998 May 27;279(20):1643-50
9613915
J Clin Invest. 1975 Mar;55(3):636-43
1117069
Biochim Biophys Acta. 2003 Mar 10;1610(2):247-57
12648778
J Thromb Haemost. 2005 May;3(5):1036-41
15869601
Thromb Res. 2010 Oct;126(4):e312-7
20451958
Nature. 2002 Dec 19-26;420(6917):868-74
12490960
Arterioscler Thromb Vasc Biol. 1995 Feb;15(2):247-51
7749833
JAMA. 2001 Apr 11;285(14):1828-9
11308379
Thromb Haemost. 2007 Jul;98(1):186-91
17598012
J Biol Chem. 2002 Sep 6;277(36):32409-12
12117999
Circulation. 2009 Jan 6;119(1):116-22
19103996
Thromb Haemost. 2001 Feb;85(2):341-8
11246558
Circulation. 1992 May;85(5):1792-8
1572035
Curr Vasc Pharmacol. 2003 Jun;1(2):157-69
15320841
Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2476-83
17761940
Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1039-45
19390055
Lancet. 2001 Aug 18;358(9281):527-33
11520521
J Biol Chem. 2004 Dec 10;279(50):52526-34
15459198
Circulation. 2009 Nov 24;120(21):2095-104
19901191
Blood. 2002 May 15;99(10):3629-36
11986217
Arterioscler Thromb Vasc Biol. 1997 Feb;17(2):273-8
9081681